Real-world check: does polatuzumab help chinese lymphoma patients?

NCT ID NCT05954910

Recruiting now Knowledge-focused Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study follows 1,000 Chinese adults with diffuse large B-cell lymphoma (a fast-growing blood cancer) who are receiving polatuzumab as part of their routine care. Researchers are tracking how long patients stay cancer-free after treatment and noting any side effects. The goal is to see how well the drug works outside of controlled clinical trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diffuse large B-cell lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIFFUSE LARGE B-CELL LYMPHOMA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Affiliated Hospital of Inner Mongolia Medical University
RECRUITING

Hohhot, 010000, China
Beijing Hospital of Ministry of Health
ACTIVE_NOT_RECRUITING

Beijing, 100730, China
Beijing Tongren Hospital, Capital Medical University
ACTIVE_NOT_RECRUITING

Beijing, 100730, China
China Medical University (CMU) First Affiliated Hospital
RECRUITING

Shenyang, 110001, China
First Affiliated Hospital of Medical College of Xi'an Jiaotong University
ACTIVE_NOT_RECRUITING

Xi'an, 710061, China
Guizhou Cancer Hospital
RECRUITING

Guiyang, 550004, China
Hainan Cancer Hospital
RECRUITING

Haikou, China
Henan Cancer Hospital
RECRUITING

Zhengzhou, China
Jiangsu Cancer Hospital
ACTIVE_NOT_RECRUITING

Nanjing, 211100, China
Jiangsu Province Hospital (the First Affiliated Hospital With Nanjing Medical University)
ACTIVE_NOT_RECRUITING

Nanjing, 210029, China
Jiangxi Cancer Hospital
RECRUITING

Nanchang, 330029, China
Peking Union Medical College Hospital
ACTIVE_NOT_RECRUITING

Beijing, 100032, China
Peking University Third Hospital
RECRUITING

Beijing, 100191, China
Ruijin Hospital Shanghai Jiaotong University School of Medicine
RECRUITING

Shanghai, 200025, China
Shanxi Province Cancer Hospital
ACTIVE_NOT_RECRUITING

Taiyuan, 030013, China
Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital
ACTIVE_NOT_RECRUITING

Chengdu, 610072, China
The Affiliated Hospital Of Qingdao University
RECRUITING

Qingdao, DUMMY_VALUE, China
The Affiliated Hospital of Xuzhou Medical University
RECRUITING

Xuzhou, China
The First Bethune Hospital of Jilin University
ACTIVE_NOT_RECRUITING

Changchun, China
The Fourth Hospital of Hebei Medical University
ACTIVE_NOT_RECRUITING

Shijiazhuang, China
Third Xiangya Hospital of Central South University
RECRUITING

Changsha, China
Tianjin Cancer Hospital
RECRUITING

Tianjin, 300060, China
Tianjin Medical University General Hospital
RECRUITING

Tianjin, 300052, China
Tongji Hospital of Tongji University
ACTIVE_NOT_RECRUITING

Shanghai, 200065, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology
ACTIVE_NOT_RECRUITING

Wuhan, 430022, China
Wuxi People's Hospital
RECRUITING

Wuxi, 214023, China
Xiangya Hospital of Centre-South University
ACTIVE_NOT_RECRUITING

Changsha, 410008, China
Xinjiang Medical University Cancer Hospital
ACTIVE_NOT_RECRUITING

Ürümqi, 830011, China
Zhujiang Hospital, Southern Medical University
ACTIVE_NOT_RECRUITING

Guangzhou, 510280, China